Breese Oncology Institute is categorized under Oncologists in Breese, IL and active since 2009.
Breese Oncology Institute was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Hassan Megahy, Office Manager at the company’s single location by writing to 14017 Jamestown Road, Breese, Illinois IL 62230 or by phoning (618) 526-7100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Breese Oncology Institute |
| Contact Person: | Hassan Megahy, Office Manager |
| Address: | 14017 Jamestown Road, Breese, Illinois 62230 |
| Phone Number: | (618) 526-7100 |
| Website Address: | breeseoncology.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Breese Oncology Institute was started in 2009 to provide professional Oncologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Hassan Megahy, Office Manager for inquiries that concern Breese Oncology Institute by calling the company number (618) 526-7100, as your correspondence is most welcome. Additionally, the physical location of the single location of Breese Oncology Institute can be found at the coordinates 38.62644,-89.5258 as well as the street address 14017 Jamestown Road in Breese, Illinois 62230.
For its online presence, you may visit Breese Oncology Institute’s website at breeseoncology.com and engage with its social media outlets through on Twitter and on Facebook.